Maree Bilandzic

27-31 Wright St
Clayton, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Podocalyxin may be down-regulated by progesterone in high grade serous ovarian cancer spheroids to increase responsiveness to carboplatin and NK cells.

Podocalyxin may be down-regulated by progesterone in high grade serous ovarian cancer spheroids to increase responsiveness to carboplatin and NK cells.

Journal: BMC cancer
Published: March 16, 2026

Podocalyxin protects high grade serous ovarian cancer spheroids from NK cell infiltration and spheroid destruction.

Podocalyxin protects high grade serous ovarian cancer spheroids from NK cell infiltration and spheroid destruction.

Journal: BMC cancer
Published: June 30, 2025

Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer.

Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer.

Journal: Current oncology (Toronto, Ont.)
Published: November 26, 2024

A Novel 3D High-Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian Cancer.

A Novel 3D High-Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian Cancer.

Journal: Advanced healthcare materials
Published: October 22, 2024

Leader Cells: Invade and Evade-The Frontline of Cancer Progression.

Leader Cells: Invade and Evade-The Frontline of Cancer Progression.

Journal: International journal of molecular sciences
Published: August 29, 2024

Leader cells promote immunosuppression to drive ovarian cancer progression in vivo.

Leader cells promote immunosuppression to drive ovarian cancer progression in vivo.

Journal: Cell reports
Published: April 09, 2024

Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma.

Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma.

Journal: Scientific reports
Published: November 23, 2023

A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer.

A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer.

Journal: Cancers
Published: October 15, 2023

Chemoresistance is mediated by ovarian cancer leader cells in vitro.

Chemoresistance is mediated by ovarian cancer leader cells in vitro.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 06, 2021

DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model.

DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model.

Journal: Cancers
Published: December 11, 2020

Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells.

Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells.

Journal: International journal of molecular sciences
Published: October 09, 2020

TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.

TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.

Journal: BMC cancer
Published: April 03, 2020
Showing 1-12 of 29

Last Updated: 09/26/2026